Connect with others who understand.

  •   Learn from expert-reviewed resources
  •   Real advice from people who’ve been there
  •   People who understand what you’re going through
Sign Up Log In
Powered By
Real members of MyAmyloidosisTeam have posted questions and answers that support our community guidelines, and should not be taken as medical advice. Looking for the latest medically reviewed content by doctors and experts? Visit our resource section.
A MyAmyloidosisTeam Member asked a question 💭
Denver, CO
April 12, 2025
 · 
Be the first to react
MyAmyloidosisTeam

For Stage 1 ATTR amyloidosis, which is characterized by normal levels of both NT-proBNP and eGFR biomarkers, patients have an average life expectancy of 5.8 years after diagnosis. This represents the best prognosis among the different stages of ATTR amyloidosis. Wild-type ATTR amyloidosis generally has a positive outlook Show Full Answer

For Stage 1 ATTR amyloidosis, which is characterized by normal levels of both NT-proBNP and eGFR biomarkers, patients have an average life expectancy of 5.8 years after diagnosis. This represents the best prognosis among the different stages of ATTR amyloidosis. Wild-type ATTR amyloidosis generally has a positive outlook, with studies showing an 85% survival rate at the one-year follow-up mark. The disease typically progresses more slowly than other forms of amyloidosis, as it develops gradually over time as amyloid deposits form. However, the presence of severe heart complications can impact the overall prognosis.

April 12, 2025

Related Questions

View All
A MyAmyloidosisTeam Member asked a question 💭

A MyAmyloidosisTeam Member asked a question 💭
Denver, CO

A MyAmyloidosisTeam Member asked a question 💭
Richmond BC Canada

Continue with Facebook
Continue with Google
By joining, you accept our Terms of Use, and acknowledge our collection, sharing, and use of your data in accordance with our Health Data and Privacy policies.
Already a member? Log In